Independence Bank of Kentucky’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-3,036
Closed -$2K 392
2020
Q4
$2K Buy
+3,036
New +$6.47K ﹤0.01% 368

Other funds holding BMY.RT

Independence Bank of Kentucky's BMY.RT Position: Q1 2021 in Review

Independence Bank of Kentucky sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 3,036 shares — an estimated $2K sold.

Independence Bank of Kentucky first reported a position in BMY.RT in Q4 2020 and held it in 1 quarter. The position peaked at $2K in Q4 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Independence Bank of Kentucky reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Independence Bank of Kentucky sold 3,036 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $2K.
  • Independence Bank of Kentucky first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2020 and held it in 1 quarter.
  • Independence Bank of Kentucky's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $2K in Q4 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Independence Bank of Kentucky's 13F filing for Q1 2021, filed 21 Apr 2021.